Insider Transactions in Q4 2025 at Tenax Therapeutics, Inc. (TENX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Stuart Rich Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+32.19%
|
$25,000
$10.22 P/Share
|
|
Dec 08
2025
|
Stuart Rich Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
2,500
+33.33%
|
$25,000
$10.1 P/Share
|
|
Dec 04
2025
|
Stuart Rich Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
2,500
+50.0%
|
$22,500
$9.2 P/Share
|
|
Dec 03
2025
|
Stuart Rich Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+35.16%
|
$13,500
$9.08 P/Share
|
|
Dec 02
2025
|
Stuart Rich Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+44.13%
|
$9,000
$9.01 P/Share
|
|
Nov 20
2025
|
Christopher Thomas Giordano CEO |
BUY
Open market or private purchase
|
Direct |
538
+17.12%
|
$3,766
$7.59 P/Share
|
|
Nov 19
2025
|
Christopher Thomas Giordano CEO |
BUY
Open market or private purchase
|
Direct |
455
+18.04%
|
$3,185
$7.51 P/Share
|
|
Nov 18
2025
|
Christopher Thomas Giordano CEO |
BUY
Open market or private purchase
|
Direct |
1,612
+50.0%
|
$11,284
$7.75 P/Share
|
|
Nov 18
2025
|
June Sherie Almenoff Director |
BUY
Open market or private purchase
|
Direct |
1,900
+48.81%
|
$13,300
$7.52 P/Share
|
|
Nov 17
2025
|
Thomas Mcgauley Interim CFO |
BUY
Open market or private purchase
|
Indirect |
6,000
+50.0%
|
$42,000
$7.29 P/Share
|
|
Nov 17
2025
|
Thomas Mcgauley Interim CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$14,000
$7.34 P/Share
|
|
Nov 17
2025
|
June Sherie Almenoff Director |
BUY
Open market or private purchase
|
Direct |
93
+50.0%
|
$651
$7.15 P/Share
|